How ABCA7 affects Alzheimer's Disease
Mechanisms by which ABCA7 activity influences Alzheimer's Disease
This study is looking at how a gene called ABCA7 affects brain health in people with Alzheimer's Disease, to help us understand how it might influence the fats in our brain that are important for thinking and memory, which could lead to new ways to treat the condition.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10525795 on NIH RePORTER |
What this research studies
This research investigates the role of the ABCA7 gene in Alzheimer's Disease (AD), which is a leading cause of dementia affecting millions. The study focuses on understanding how ABCA7 influences lipid metabolism and transport in the brain, which is crucial for maintaining cognitive function. By examining genetic variants associated with AD risk, the research aims to uncover the specific lipids that ABCA7 transports and how these mechanisms contribute to the development of Alzheimer's. This could lead to new insights into potential therapeutic targets for AD.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at risk for Alzheimer's Disease, particularly those with genetic predispositions related to the ABCA7 gene.
Not a fit: Patients with Alzheimer's Disease who do not have any genetic variants associated with ABCA7 may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing or treating Alzheimer's Disease.
How similar studies have performed: Previous research has shown promising results in understanding the genetic factors influencing Alzheimer's Disease, suggesting that this approach could yield valuable insights.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Rader, Daniel James — University of Pennsylvania
- Study coordinator: Rader, Daniel James
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.